337 related articles for article (PubMed ID: 24382831)
1. Development of at-line assay to monitor charge variants of MAbs during production.
St Amand MM; Ogunnaike BA; Robinson AS
Biotechnol Prog; 2014; 30(1):249-55. PubMed ID: 24382831
[TBL] [Abstract][Full Text] [Related]
2. An empirical modeling platform to evaluate the relative control discrete CHO cell synthetic processes exert over recombinant monoclonal antibody production process titer.
McLeod J; O'Callaghan PM; Pybus LP; Wilkinson SJ; Root T; Racher AJ; James DC
Biotechnol Bioeng; 2011 Sep; 108(9):2193-204. PubMed ID: 21445882
[TBL] [Abstract][Full Text] [Related]
3. Integrated continuous production of recombinant therapeutic proteins.
Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
[TBL] [Abstract][Full Text] [Related]
4. Process performance and product quality in an integrated continuous antibody production process.
Karst DJ; Steinebach F; Soos M; Morbidelli M
Biotechnol Bioeng; 2017 Feb; 114(2):298-307. PubMed ID: 27497430
[TBL] [Abstract][Full Text] [Related]
5. Impact of mammalian cell culture conditions on monoclonal antibody charge heterogeneity: an accessory monitoring tool for process development.
Sissolak B; Lingg N; Sommeregger W; Striedner G; Vorauer-Uhl K
J Ind Microbiol Biotechnol; 2019 Aug; 46(8):1167-1178. PubMed ID: 31175523
[TBL] [Abstract][Full Text] [Related]
6. Effect of sodium butyrate on the assembly, charge variants, and galactosylation of antibody produced in recombinant Chinese hamster ovary cells.
Hong JK; Lee SM; Kim KY; Lee GM
Appl Microbiol Biotechnol; 2014 Jun; 98(12):5417-25. PubMed ID: 24557571
[TBL] [Abstract][Full Text] [Related]
7. Synchronous fluorescence spectroscopy as a novel tool to enable PAT applications in bioprocesses.
Teixeira AP; Duarte TM; Carrondo MJ; Alves PM
Biotechnol Bioeng; 2011 Aug; 108(8):1852-61. PubMed ID: 21391211
[TBL] [Abstract][Full Text] [Related]
8. Development of a scale down cell culture model using multivariate analysis as a qualification tool.
Tsang VL; Wang AX; Yusuf-Makagiansar H; Ryll T
Biotechnol Prog; 2014; 30(1):152-60. PubMed ID: 24124180
[TBL] [Abstract][Full Text] [Related]
9. Probing of C-terminal lysine variation in a recombinant monoclonal antibody production using Chinese hamster ovary cells with chemically defined media.
Luo J; Zhang J; Ren D; Tsai WL; Li F; Amanullah A; Hudson T
Biotechnol Bioeng; 2012 Sep; 109(9):2306-15. PubMed ID: 22473810
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of the glycosylation of a monoclonal antibody produced under nominally identical cell culture conditions in two different bioreactors.
Kunkel JP; Jan DC; Butler M; Jamieson JC
Biotechnol Prog; 2000; 16(3):462-70. PubMed ID: 10835250
[TBL] [Abstract][Full Text] [Related]
11. Case Study: an accelerated 8-day monoclonal antibody production process based on high seeding densities.
Padawer I; Ling WL; Bai Y
Biotechnol Prog; 2013; 29(3):829-32. PubMed ID: 23596148
[TBL] [Abstract][Full Text] [Related]
12. Defining process design space for monoclonal antibody cell culture.
Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
[TBL] [Abstract][Full Text] [Related]
13. Discovery and characterization of CHO host cell protease-induced fragmentation of a recombinant monoclonal antibody during production process development.
Yang B; Li W; Zhao H; Wang A; Lei Y; Xie Q; Xiong S
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():1-10. PubMed ID: 30836312
[TBL] [Abstract][Full Text] [Related]
14. Online integrity monitoring in the protein A step of mAb production processes-increasing reliability and process robustness.
Bork C; Holdridge S; Walter M; Fallon E; Pohlscheidt M
Biotechnol Prog; 2014; 30(2):383-90. PubMed ID: 24376144
[TBL] [Abstract][Full Text] [Related]
15. Cation exchange-HPLC and mass spectrometry reveal C-terminal amidation of an IgG1 heavy chain.
Johnson KA; Paisley-Flango K; Tangarone BS; Porter TJ; Rouse JC
Anal Biochem; 2007 Jan; 360(1):75-83. PubMed ID: 17113563
[TBL] [Abstract][Full Text] [Related]
16. Identification of multiple sources of the acidic charge variants in an IgG1 monoclonal antibody.
Miao S; Xie P; Zou M; Fan L; Liu X; Zhou Y; Zhao L; Ding D; Wang H; Tan WS
Appl Microbiol Biotechnol; 2017 Jul; 101(14):5627-5638. PubMed ID: 28439623
[TBL] [Abstract][Full Text] [Related]
17. Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability.
Dillon TM; Bondarenko PV; Rehder DS; Pipes GD; Kleemann GR; Ricci MS
J Chromatogr A; 2006 Jul; 1120(1-2):112-20. PubMed ID: 16448656
[TBL] [Abstract][Full Text] [Related]
18. Stimuli-responsive magnetic nanoparticles for monoclonal antibody purification.
Borlido L; Moura L; Azevedo AM; Roque AC; Aires-Barros MR; Farinha JP
Biotechnol J; 2013 Jun; 8(6):709-17. PubMed ID: 23420794
[TBL] [Abstract][Full Text] [Related]
19. Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile.
Reid CQ; Tait A; Baldascini H; Mohindra A; Racher A; Bilsborough S; Smales CM; Hoare M
Biotechnol Bioeng; 2010 Sep; 107(1):85-95. PubMed ID: 20506289
[TBL] [Abstract][Full Text] [Related]
20. Development of a new bioprocess scheme using frozen seed train intermediates to initiate CHO cell culture manufacturing campaigns.
Seth G; Hamilton RW; Stapp TR; Zheng L; Meier A; Petty K; Leung S; Chary S
Biotechnol Bioeng; 2013 May; 110(5):1376-85. PubMed ID: 23242970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
